ABBVIE
A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 45
- Registration Number
- NCT02009631
- Locations
- 🇳🇱
Site Reference ID/Investigator# 117320, Groningn, Netherlands
🇺🇸Site Reference ID/Investigator# 116015, Scottsdale, Arizona, United States
🇳🇱Site Reference ID/Investigator# 117336, Maastricht, Netherlands
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
- Conditions
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 89
- Registration Number
- NCT01995071
A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)
- Conditions
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 32
- Registration Number
- NCT01994837
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 12
- Registration Number
- NCT01969669
- Locations
- 🇺🇸
Site Reference ID/Investigator# 97498, Tucson, Arizona, United States
🇺🇸Site Reference ID/Investigator# 92593, Lebanon, New Hampshire, United States
🇺🇸Site Reference ID/Investigator# 101415, Hackensack, New Jersey, United States
An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2019-12-19
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 11
- Registration Number
- NCT01969695
- Locations
- 🇺🇸
University of Arizona Arthritis Center /ID# 101359, Tucson, Arizona, United States
🇺🇸Dartmouth-Hitchcock Med Ctr /ID# 92596, Lebanon, New Hampshire, United States
🇺🇸Hackensack Univ Med Ctr /ID# 101417, Hackensack, New Jersey, United States
A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- AbbVie
- Registration Number
- NCT01969682
- Locations
- 🇺🇸
Site Reference ID/Investigator# 101416, Hackensack, New Jersey, United States
Evaluation of Diet and Exercise in Prostate Cancer Patients
- Conditions
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 1331
- Registration Number
- NCT01960881
- Locations
- 🇨🇦
Exdeo Clinical Research Inc /ID# 116040, Abbotsford, British Columbia, Canada
🇨🇦Dr. J. Paul Whelan, Inc. /ID# 120415, Victoria, British Columbia, Canada
🇨🇦QE II Health Sciences Centre /ID# 118941, Halifax, Nova Scotia, Canada
Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
- Conditions
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 473
- Registration Number
- NCT01960790
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
- Conditions
- Interventions
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 31
- Registration Number
- NCT01960842
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 276
- Registration Number
- NCT01960855